Insulin-like growth factors and pancreas beta cells

Area of Science:

• Endocrinology
• Developmental Biology
• Metabolic Diseases

Background:

• Insulin-like growth factors (IGFs) play a vital role in normal growth, particularly fetal pancreas beta-cell development.
• Low birth weight is associated with increased risk of obesity and type 2 diabetes, highlighting the importance of IGF signaling.
• IGF-I signaling shares similarities with insulin signaling, mediating effects like anti-apoptosis, protein synthesis, cell growth, and mitogenesis.

Discussion:

• Insulin receptor A and IGF-1 receptor bind Insulin-like growth factor-II, potentially explaining its antiapoptotic function.
• Knock-out studies demonstrate the critical role of IGF-I and IGF-1 receptor in fetal and postnatal growth.
• Defective IGF-II synthesis in Goto-Kakizaki rats, a diabetes model, correlates with insufficient beta-cell development.

Key Insights:

• Absence of IGF-I or IGF-1 receptor severely impacts fetal and postnatal growth.
• Post-receptor molecules like IRS-2 are essential for pancreas beta-cell development, as shown in knock-out models.
• A beta-cell-specific IGF-1 receptor knock-out model underscores IGF-I's importance for beta-cell function.

Outlook:

• Further research into the interaction between insulin resistance and IGF signaling in pancreas beta cells is warranted.
• Understanding IGF pathways could offer new therapeutic targets for type 2 diabetes and related metabolic disorders.
• Investigating IGF's role in beta-cell adaptation to insulin resistance may reveal mechanisms underlying diabetes development.